Clew (Decision/Risk Analysis) Overview

  • Founded
  • 2014

  • Status
  • Private

  • Employees
  • 30

  • Latest Deal Type
  • Series B

  • Latest Deal Amount
  • $10M

  • Investors
  • 7

Clew (Decision/Risk Analysis) General Information


Developer of a predictive analytics platform designed to guide healthcare providers in predicting the patient's clinical state. The company's platform utilizes machine learning analytics that helps to predict life-threatening deterioration in real-time and delivers predictive warnings during all phases of a patient's stay in the ICU, enabling healthcare providers to provide an informed clinical decisions to their patients.

Contact Information

Formerly Known As
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Decision/Risk Analysis
Other Industries
Other Healthcare Technology Systems
Primary Office
  • 5 Hamelecha Street
  • Poleg
  • Netanya 4250574
  • Israel
+972 00-000-0000

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Clew (Decision/Risk Analysis) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
7. Later Stage VC (Series B) 15-Jan-2020 $10M 0000 Completed Generating Revenue
6. Early Stage VC 27-Dec-2017 000.00 0000 Completed Generating Revenue
5. Early Stage VC (Series A) 08-Feb-2017 00.00 000.00 Completed Generating Revenue
4. Accelerator/Incubator 09-Jun-2016 000.00 00.00 Completed Generating Revenue
3. Accelerator/Incubator 01-Jan-2016 00.00 Completed Generating Revenue
2. Accelerator/Incubator 20-Oct-2015 $2.2M Completed Generating Revenue
1. Seed Round 01-Jan-2015 $2.2M $2.2M Completed Generating Revenue
To view Clew (Decision/Risk Analysis)’s complete valuation and funding history, request access »

Clew (Decision/Risk Analysis) Executive Team (14)

Name Title Board Seat Contact Info
Paul Roscoe Chief Executive Officer & Board Member
Itai Pessach Medical Director & Board Member
Gal Salomon Co-Founder & Executive Chairman
Assaf Zeevi Ph.D Chief Scientist & Scientific Advisory Board
Avigdor Faians Co-Founder & Chief Scientific and Regulatory Officer
You’re viewing 5 of 14 executive team members. Get the full list »

Clew (Decision/Risk Analysis) Board Members (9)

Name Representing Role Since
Ariel Moses Agate Medical Investments Board Member 000 0000
Barbara Lubash Self Board Member 000 0000
Daniel Talmor Self Board Member 000 0000
Itai Pessach Clew (Decision/Risk Analysis) Medical Director & Board Member 000 0000
Ittai Harel Pitango Venture Capital Board Member 000 0000
You’re viewing 5 of 9 board members. Get the full list »

Clew (Decision/Risk Analysis) Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Clew (Decision/Risk Analysis) Investors (7)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Relyens Impact Investing Minority 000 0000 000000 0
Agate Medical Investments Venture Capital Minority 000 0000 000000 0
8200 EISP Accelerator/Incubator 000 0000 000000 0
MedTech Innovator Accelerator/Incubator 000 0000 000000 0
Healthbox Accelerator/Incubator 000 0000 000000 0
You’re viewing 5 of 7 investors. Get the full list »